Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2004Blood Coagulation & Fibrinolysis

Factor V inhibitors

View Full Paper
Ask AI
Bookmark
Share

Authors

EFEmmanuel J. FavaloroVascular MedicineJPJennifer PosenRRRaj RamakrishnaUniversity of Wollongong

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Favaloro et al. (2004) studied this question.

synapsesocial.com/papers/6a70e42835aa2c282ce23871https://doi.org/10.1097/00001721-200412000-00003
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Acquired factor V inhibitor complicated by Hashimoto's thyroditis, primary biliary cirrhosis and membranous nephropathy2003 · 38 citations
  2. 2Deep-vein thrombosis and coumarin skin necrosis associated with a factor V inhibitor with lupus-like features1998 · 47 citations
  3. 3Acquired inhibitors to coagulation factors in patients with gastrointestinal diseases2002 · 42 citations
  4. 4High‐dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors2003 · 53 citations